您的位置： 百康网 > 期刊 > 肿瘤学 > 《临床肿瘤学医学期刊》 > 2005年 > 2005年11月第11期 ·07/06/15 Phase I and Pharmacokinetics Trial of ABI-007, a Novel Nanoparticle Formulation of Paclitaxel in Patients With Advanced Nonhematologic Malignancies ·07/06/15 Epidermal Growth Factor Receptor Mutations and Gene Amplification in Non–Small-Cell Lung Cancer: Molecular Analysis of the IDEAL/INTACT Gefitinib Trials ·07/06/15 Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epide ·07/06/15 Reversibility of Trastuzumab-Related Cardiotoxicity: New Insights Based on Clinical Course and Response to Medical Treatment ·07/06/15 Squamous Cell Carcinoma of the Breast ·07/06/15 Breast Cancer Trends Among Black and White Women in the United States ·07/06/15 Tamoxifen Versus Control After Adjuvant, Risk-Adapted Chemotherapy in Postmenopausal, Receptor-Negative Patients With Breast Cancer: A Randomized Trial (GABG-IV D-93)—The German Adjuvant Breast Cance ·07/06/15 Satisfaction After Contralateral Prophylactic Mastectomy: The Significance of Mastectomy Type, Reconstructive Complications, and Body Appearance ·07/06/15 18F-Fluorodeoxyglucose Positron Emission Tomography Contributes to the Diagnosis and Management of Infections in Patients With Multiple Myeloma: A Study of 165 Infectious Episodes ·07/06/15 Randomized Trial of Prevention of Catheter-Related Bloodstream Infection by Continuous Infusion of Low-Dose Unfractionated Heparin in Patients With Hematologic and Oncologic Disease ·07/06/15 Phase I and Pharmacokinetic Study of Aplidine, a New Marine Cyclodepsipeptide in Patients With Advanced Malignancies ·07/06/15 Geographic and Socioeconomic Variation in the Treatment of Prostate Cancer ·07/06/15 Treatment of Metastatic Renal Cell Carcinoma With a Combination of Bevacizumab and Erlotinib ·07/06/15 Gonadotropin-Releasing Hormone Agonists and Fracture Risk: A Claims-Based Cohort Study of Men With Nonmetastatic Prostate Cancer ·07/06/15 Therapy Tolerance in Selected Patients With Androgen-Independent Prostate Cancer Following Strontium-89 Combined With Chemotherapy ·07/06/15 Unique Gene Expression Profile Based on Pathologic Response in Epithelial Ovarian Cancer ·07/06/15 Response of Retinoblastoma With Vitreous Tumor Seeding to Adenovirus-Mediated Delivery of Thymidine Kinase Followed by Ganciclovir ·07/06/15 Risk of Adverse Events After Completion of Therapy for Childhood Acute Lymphoblastic Leukemia ·07/06/15 Prospective Study Using the Risk of Ovarian Cancer Algorithm to Screen for Ovarian Cancer ·07/06/15 Long-Term Outcome in Children With Relapsed ALL by Risk-Stratified Salvage Therapy: Results of Trial Acute Lymphoblastic Leukemia-Relapse Study of the Berlin-Frankfurt-Münster Group 87 ·07/06/15 Catenin Status Predicts a Favorable Outcome in Childhood Medulloblastoma: The United Kingdom Children's Cancer Study Group Brain Tumour Committee ·07/06/15 Length of Stay and Mortality Associated With Febrile Neutropenia Among Children With Cancer ·07/06/15 Recruiting African American Women to Participate in Hereditary Breast Cancer Research ·07/06/15 Prevention of Chemotherapy-Induced Febrile Neutropenia by Prophylactic Antibiotics Plus or Minus Granulocyte Colony-Stimulating Factor in Small-Cell Lung Cancer: A Dutch Randomized Phase III Study ·07/06/15 Re-Treatment With I-131 Tositumomab in Patients With Non-Hodgkin's Lymphoma Who Had Previously Responded to I-131 Tositumomab ·07/06/15 High-Dose Therapy and Autologous Hematopoietic Stem-Cell Transplantation Does Not Increase the Risk of Second Neoplasms for Patients With Hodgkin's Lymphoma: A Comparison of Conventional Therapy Alone ·07/06/15 Role of Hematotoxicity and Sex in Patients With Hodgkin's Lymphoma: An Analysis From the German Hodgkin Study Group ·07/06/15 Prognostic Significance of BACH2 Expression in Diffuse Large B-Cell Lymphoma: A Study of the Osaka Lymphoma Study Group ·07/06/15 Long-Term Follow-Up of Gastric MALT Lymphoma After Helicobacter Pylori Eradication ·07/06/15 Phase II Trial of Bevacizumab Plus Gemcitabine in Patients With Advanced Pancreatic Cancer ·07/06/15 An Intensive Surveillance Program Detected a High Incidence of Hepatocellular Carcinoma Among Hepatitis B Virus Carriers With Abnormal Alpha-Fetoprotein Levels or Abdominal Ultrasonography Results ·07/06/15 Biologic and Prognostic Significance of Dermal Ki67 Expression, Mitoses, and Tumorigenicity in Thin Invasive Cutaneous Melanoma ·07/06/15 Variates of Survival in Metastatic Uveal Melanoma ·07/06/15 Pathogenesis of Myelofibrosis With Myeloid Metaplasia ·07/06/15 A Population-Based Validation of the American Joint Committee on Cancer Melanoma Staging System 首 页　上一页 下一页 尾 页　页次：[nowpage]/[countpage]页　[maxpage]篇/页　共 60 篇　转到第 页

栏目导航 ·2005年1月第1期 ·2005年2月第2期 ·2005年3月第3期 ·2005年4月第4期 ·2005年5月第5期 ·2005年6月第6期 ·2005年7月第7期 ·2005年8月第8期 ·2005年9月第9期 ·2005年10月第10期 ·2005年11月第11期 ·2005年12月第12期